Rounding at Rush spotlights the work of physicians across the Rush University System for Health, comprised of two community hospitals and Rush University Medical Center, which is ranked by U.S. News & World Report as one of the nation’s best hospitals. As a leading health system, Rush delivers outstanding patient care, offers the latest treatments, educates the next generation of health care providers, and pursues groundbreaking research. Accreditation Statement In support of improving patient care, Rush University Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the health care team. This activity is being presented without bias and with/without commercial support. Designation Statement Rush University Medical Center designates this internet enduring material activity for a maximum of One (1) AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity. Disclosures The course director(s), planner(s), faculty and reviewer(s) of this activity have no relevant financial relationships to disclose.
Episodes
Monday Jul 31, 2023
Monday Jul 31, 2023
The RUSH Parkinson's Disease and Movement Disorders program treats over 7,000 patients with movement disorders, the majority of whom have Parkinson's disease (PD). RUSH is currently conducting about 150 research projects related to movement disorders; half of those focus on PD. Research on PD at RUSH encompasses a wide breadth of inquiry, from clinical phenotypes to pharmacologic interventions and much more.
Deborah Hall, MD, is a neurologist and movement disorder specialist and the Division Chief of the Section of Movement Disorders at RUSH University Medical Center. She also co-leads the novel RUSH PD GI Clinic, a novel multidisciplinary clinic focused on the gastrointestinal health of patients with PD and other movement disorders.
“Gene-based therapies are a particularly exciting area of research. Over the last five years, RUSH’s goal has been to personalize treatment for PD patients. This particular strategy coincides very nicely with the worldwide gene discovery effort to look at the genetic causes of Parkinson's disease.”
CME Link: https://cmetracker.net/RUSH/Publisher?page=pubOpenSub#/event/489645/
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.